New hope for lymphoma patients who Can't tolerate standard drugs
NCT ID NCT04116437
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called zanubrutinib in 96 people with certain types of B-cell lymphoma (like chronic lymphocytic leukemia or mantle cell lymphoma) who had bad side effects from similar drugs like ibrutinib or acalabrutinib. The main goal was to see if zanubrutinib causes fewer or less severe side effects. Researchers also checked if the drug helped control the cancer. This is not a cure, but a way to manage the disease with ongoing treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Abington Hematology Oncology Associates
Horsham, Pennsylvania, 19044-2331, United States
-
Baylor Research Institute
Dallas, Texas, 75246-2079, United States
-
Christiana Care
Newark, Delaware, 19713-2055, United States
-
Clinical Research Alliance, Inc
Westbury, New York, 11590-5119, United States
-
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, 89169-3321, United States
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109-4433, United States
-
Healthcare Research Network Iii, Llc
Flossmoor, Illinois, 60422-2067, United States
-
Medical Oncology Associates
Spokane, Washington, 99208-1129, United States
-
Minnesota Oncology Burnsville Clinic
Burnsville, Minnesota, 55337-6749, United States
-
Morristown Medical Center
Morristown, New Jersey, 07960-6136, United States
-
Oncology Associates of Oregon Willamette Valley Cancer Center
Eugene, Oregon, 97401, United States
-
Rocky Mountain Cancer Centers (Williams) Usor
Aurora, Colorado, 80012-5405, United States
-
Scri Florida Cancer Specialists North
St. Petersburg, Florida, 33705-1449, United States
-
Scri Florida Cancer Specialists South
Fort Myers, Florida, 33901-8108, United States
-
Ssm Health Cancer Care Dean Medical Center
Madison, Wisconsin, 53717-1959, United States
-
St Century Oncology
Jacksonville, Florida, 32204-1128, United States
-
St Lukes University Health Network
Fountain Hill, Pennsylvania, 18015-1153, United States
-
Summit Medical Group
Florham Park, New Jersey, 07932-1049, United States
-
Tennessee Oncology, Pllc Nashville
Nashville, Tennessee, 37203, United States
-
Texas Oncology Amarillo
Amarillo, Texas, 79106-1781, United States
-
Texas Oncology McAllen South Second Street
McAllen, Texas, 78503, United States
-
Texas Oncology Tyler Longview
Austin, Texas, 78705-1163, United States
-
Us Oncology Virginia Cancer Specialists, Pc
Fairfax, Virginia, 22031-4629, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502-2800, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive drug outperform standard therapy in waldenstrom macroglobulinemia?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a Triple-Drug combo wipe out Slow-Growing lymphomas?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can donor immune cells be engineered to fight blood cancer?
- Can a targeted drug boost standard therapy for a rare lymphoma?